Publications

Total found: 95 records
Duraisamy S., Bhosale D., Lipenska I., Huvarová I., Růžek D., Windisch M.P., Miller A. (2020) Advanced therapeutics, vaccinations, and precision medicine in the treatment and management of chronic Hepatitis B viral infections: where are we and where are we going? Viruses-Basel 12: 998.
DOI: 10.3390/v12090998
Gejji V. , Svoboda P., Štefánik M., Wang H., Salát J., Eyer L., Růžek D., Fernando S. (2020) An RNA-dependent RNA polymerase inhibitor for tick-borne encephalitis virus(Article) Virology 546: 13–19.
DOI: 10.1016/j.virol.2020.03.006
Lattová E., Straková P., Pokorná Formanová P., Grubhoffer L., Bell-Sakyi L., Zdráhal Z., Palus M., Růžek D. (2020) Comprehensive N-glycosylation mapping of envelope glycoprotein from tick-borne encephalitis virus grown in human and tick cells Scientific Reports 10: 13204.
DOI: 10.1038/s41598-020-70082-2
Procházková E. , Hřebabecký H., Dejmek M., Šála M., Šmídková M., Tloušťová E., Zborníková E., Eyer L., Růžek D., Nencka R. (2020) Could 5 '-N and S ProTide analogues work as prodrugs of antiviral agents? Bioorganic&MedicinalChemistryLetters 30: 126897.
DOI: 10.1016/j.bmcl.2019.126897
Salát J., Mikulášek K., Larralde O., Pokorná Formanová P., Chrdle A., Haviernik J., Elsterová J., Teislerová D., Palus M., Eyer L., Zdráhal Z., Petrik J., Růžek D. (2020) Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals. Vaccines 8: 81.
DOI: 10.3390/vaccines8010081
Štefánik M., Valdés J. J., Ezebuo F.C., Haviernik J., Uzochukwu I.C., Fojtikova M., Salát J., Eyer L., Růžek D. (2020) FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells Microorganisms 8: 599.
DOI: 10.3390/microorganisms8040599
Vancová M., Bílý T., Šimo L., Touš J., Horodyský P., Růžek D., Novobilský A., Salat J., Strnad M., Sonenshine D.E., Grubhoffer L., Nebesářová J. (2020) Three-dimensional reconstruction of the feeding apparatus of the tick Ixodes ricinus (Acari: Ixodidae): a new insight into the mechanism of blood-feeding Scientific Reports 10: 165.
DOI: 10.1038/s41598-019-56811-2
Berčič R.L., Bányai K., Růžek D., Fehér E., Domán M., Danielová V., Bakonyi T., Nowotny N. (2019) Phylogenetic analysis of Lednice Orthobunyavirus Microorganisms 7: 447.
DOI: 10.3390/microorganisms7100447
Dufková P., Širmarová J., Salát J., Hönig V., Palus M., Růžek D., Fooks A., Mansfield K.L., Tordo N., Jochmans D., Neyts J., Byron M., Koraka P., Osterhaus A.D.M.E., Asklepios consortium (2019) Mannitol treatment is not effective in therapy of rabies virus infection in mice Vaccine 37: 4710–4714.
DOI: 10.1016/j.vaccine.2017.12.028
Eyer L., Fojtikova M., Nencka R., Rudolf I., Hubálek Z., Růžek D. (2019) Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection Antimicrobial Agents and Chemotherapy 63: e02093-18.
DOI: 10.1128/AAC.02093-18
Eyer L., Nougairède A., Uhlířová M., Driouich J.S., Zouharova D., Valdés J. J., Haviernik J., Gould E., De Clercq E., de Lamballerie X., Růžek D. (2019) An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. Journal of Virology 93: pii: e00367-19.
DOI: 10.1128/JVI.00367-19
Hönig V., Palus M., Kašpar T., Majerová K., Zemanová M., Hofmannová L., Papežík P. , Šikutová S., Rettich F., Hubálek Z., Rudolf I., Votýpka J., Modrý D., Růžek D. (2019) Multiple Lineages of Usutu Virus (Flaviviridae, Flavivirus) in Blackbirds (Turdus merula) and Mosquitoes (Culex pipiens, Cx. modestus) in the Czech Republic (2016–2019) Microorganisms 7: 568.
DOI: 10.3390/microorganisms7110568
Hönig V., Švec P., Marek L., Mrkvička T., Zubrikova D., Wittmann M., Masař O., Szturcová D., Růžek D., Pfister K., Grubhoffer L. (2019) Model of Risk of Exposure to Lyme Borreliosis and Tick-Borne Encephalitis Virus-Infected Ticks in the Border Area of the Czech Republic (South Bohemia) and Germany (Lower Bavaria and Upper Palatinate) International Journal of Environmental Research and Public Health 16: 1173.
DOI: 10.3390/ijerph16071173
Krol E., Wandzik I., Brzuska G., Eyer L., Růžek D., Szewczyk B. (2019) Antiviral Activity of Uridine Derivatives of 2-Deoxy Sugars against Tick-Borne Encephalitis Virus Molecules 24: 1129.
DOI: 10.3390/molecules24061129
Marosi A., Dufkova L., Forró B., Felde O., Erdélyi K., Širmarová J., Palus M., Hönig V., Salát J., Tikos R., Gyuranecz M., Růžek D., Byron M., Koraka P., Osterhaus A.D.M.E., Bakonyi T. (2019) Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin Vaccine 37: 4724–4735.
DOI: 10.1016/j.vaccine.2018.05.066
Pokorná Formanová P., Palus M., Salát J., Hönig V., Štefánik M., Svoboda P., Růžek D. (2019) Changes in cytokine and chemokine profiles in mouse serum and brain, and in human neural cells, upon tick-borne encephalitis virus infection Journal of neuroinflammation 16: 205.
DOI: 10.1186/s12974-019-1596-z
Růžek D., Avšič Županc T., Borde J., Chrdle A., Eyer L., Karganova G. , Kholodilov I., Knap N., Kozlovskya L., Matveev A., Miller A., Osoldkin D.I., Överby A.K., Titukonova N. , Tkachev S., Zajkowska J. (2019) Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines Antiviral Research 164: 23–51.
DOI: 10.1016/j.antiviral.2019.01.014
Růžek D., Yoshii K., Bloom M.E., Gould E. (2019) Tick-borne encephalitis virus – virology. In: G. Dobler, W. Erber, H.J. Schmitt (Eds.), The TBE Book. Global Health Press, Singapore 19–41.
DOI: 10.33442/978-981-14-0914-1_2a
Zelená H., Straková P., Heroldová M., Mrázek J., Kastl T., Žákovská A., Růžek D., Smetana J., Rudolf I. (2019) Molecular epidemiology of hantaviruses in the Czech Republic Emerging Infectious Diseases 25: 11.
DOI: 10.3201/eid2511.190449
Eyer L., Nencka R., De Clercq E., Seley-Radtke K., Růžek D. (2018) Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. vAntiviral Chemistry and Chemotherapy 26: 1-28.
DOI: 10.1177/2040206618761299

CONTACT

Biology Centre CAS
Institute of Parasitology
Branišovská 1160/31
370 05 České Budějovice

Staff search